The global testosterone test market recorded a market valuation of US$ 100.0 million in 2023 and is expected to expand at a CAGR rate of 6.9% to reach a valuation of US$ 208.1 million by 2034. North America is leading the market with a share of about 32.4% within the global market.
The operation of male sexual organs and their regular growth depend on the levels of the hormone testosterone. It regulates sex drive, preserves muscular mass, and aids in sperm production in adult men. Testosterone is also found in females in a very small amount in the ovaries. Also, it is produced by the adrenal glands in both males and females.
In the testosterone test, the blood testosterone levels are measured. Most of the testosterone in the blood is protein-bound. The testosterone that is unattached to a protein is called free testosterone. First, the total testosterone test, which measures both attached and free testosterone, is one of the two primary testosterone assays. The second test solely measures free testosterone, and the free testosterone test can reveal more information about some medical issues. In both men and women, low or excessive testosterone levels can cause health problems.
Key Attributes | Market Insights |
---|---|
Testosterone Test Market Value, 2023 | US$ 100.0 million |
Estimated Market Value 2024 | US$ 106.6 million |
Projected Market Value 2034 | US$ 208.1 million |
CAGR (2024 to 2034) | 6.9% |
Market Share of Top 5 Countries | 58.5% |
Key Market Players | Medical EXPO, Abbexa, Imaware, LetsGetChecked, Everlywell, Boditech, myLAB Box, Verisana, Ro, Cerascreen, MediChecks, Genway Biotech, Hone Health, Humankind Ventures Ltd., Diagnostic Automation/Cortez Diagnostics Inc., Myclinic.ie, Healthy Human Labs Ltd., MyBioSource, Bluecrest Wellness and Testochecker |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2023, the market for testosterone tests represented around 22.5% of the total global fertility testing market.
The market for testosterone tests has grown at a CAGR of 5.1% from 2019 to 2023, driven by an increase in demand due to rising rates of infertility, erectile dysfunction, testicular cancer, and delayed puberty.
Historical Market Value, 2023 | US$ 100.0 million |
---|---|
HCAGR, 2019 to 2033 | 5.1% |
The testosterone tests are performed using blood, saliva, and urine. The testing kits are not only used for testosterone but are now developed by combining several other hormone tests. Thus, advancements in the kit made it possible to diagnose the disease with one kit. Also, the results obtained are much easier to read and understand. The customization of the results based on age is also provided by the companies. The samples taken are pain-free and are easy to collect.
Few of the companies provide video instructions for every step to be performed, which make it easy for the patients to use and they are also provided with live support access. Also, the patients are provided with personalized medical advice with results.
The improper balance of testosterone levels in the body can lead to testicular cancer. Also in females, high levels of testosterone are proven to be the reason for developing conditions like polycystic ovarian syndrome (PCOS). The rising number of PCOS in females has also added to the growth of the testosterone test market.
Hence, owing to the factors mentioned above, the global testosterone test market is projected to grow at a CAGR of 6.9% from 2023 to 2033.
There is a growing awareness regarding the importance of testosterone levels in various health conditions, including hypogonadism, infertility, and sexual dysfunction. This awareness has led to an increased demand for testosterone testing, driving market growth.
Male infertility is a significant concern worldwide, and testosterone testing is an essential component of the diagnostic process. With the increasing prevalence of male infertility, the demand for testosterone tests is expected to rise, presenting growth prospects for the market. Also, several other factors like testicular cancer, delayed puberty, increasing infertility, and low testosterone levels are expected to drive the demand for testosterone test kits over the forecast period.
The testosterone test market has significant growth potential in emerging and developing economies. Factors such as increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about hormonal disorders contribute to the market's expansion in these regions.
The unawareness among the population regarding the availability of these test kits and also, the lack of knowledge about using the kits is a key factor that affects the growth of the market.
Testosterone tests can be expensive, especially when advanced technologies and specialized equipment are involved. The cost factor can limit access to testing for individuals with limited financial resources, impacting market growth. The cost of kits used for testosterone tests is comparatively higher than the laboratory testing. This makes it unconventional to use in developing and underdeveloped countries.
Testosterone tests are performed with blood or saliva. The tests using saliva as the sample in the test kit are still questioned regarding the accuracy of the results. The market's growth throughout the forecast period may be impacted by all of the above-mentioned variables.
Countries | CAGR (2024 to 2034) |
---|---|
United States | 6.4% |
Germany | 3.9% |
India | 7.0% |
United Kingdom | 6.7% |
Accounting for a market share of 89.9%, the United States is leading the market in North America.
Infertility is a key concern and a common problem in males. Infertility in males is rising in the United States. Infertility issues in men are increasing this market in this region.
Testosterone imbalances, such as hypogonadism, are becoming more prevalent in the United States population. Factors such as sedentary lifestyles, obesity, stress, and aging contribute to the rising incidence of these conditions. The need for diagnosing and monitoring testosterone levels drives the demand for testosterone tests.
The Indian market for testosterone tests hold a share of 50.0% of the South Asian market.
Erectile dysfunction is a common complication observed in India. Erectile dysfunction is observed to be common among type 2 diabetes patients. Also, other factors are adding to the erectile dysfunction in males. Thus, it is expected to increase the market for testosterone tests.
The United Kingdom is expected to rise at a CAGR of 6.7% over the forecast period.
Low levels of testosterone cause testicular cancer, increasing the demand for testosterone testing in the country. Similar to other developed countries, the United Kingdom is witnessing a rise in the prevalence of testosterone-related disorders such as hypogonadism.
Lifestyle factors, the aging population, and other health conditions contribute to the increased incidence of testosterone imbalances. This drives the demand for testosterone tests for diagnosis and monitoring.
Germany held a significant share of 27.1% of the Europe testosterone test market.
The increasing healthcare expenditure and the rise in disposable income are the main reasons for boosting the market growth of testosterone tests in Germany. Other than this, the rise in awareness about the importance of testosterone for overall health and well-being is also fuelling market growth. This has led to an increased demand for testosterone tests among men of all age groups.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The blood sample for testosterone tests had a prominent market share of 45.2% in 2024. The segment is anticipated to grow at a CAGR of 7.0% during the forecast period.
Top Sample Type | Blood Sample |
---|---|
Market Share in 2024 | 45.2% |
Blood samples are commonly used samples for testing any kind of hormone. The blood samples are considered to give accurate results as compared to any other samples. The reliability of the results makes it the most used and preferred sample for testosterone testing.
Males are the ones who are undergoing testosterone tests in a large number accounting for 84.5% market share.
Top Gender | Males |
---|---|
Market Share in 2024 | 84.5% |
Testosterone plays an important role in males. The deficiency or rise in the levels of testosterone causes many problems in males which makes it necessary to have a record of the testosterone levels. As males are mostly affected by the levels of testosterone, therefore they hold a significant market share of this market.
Top End-use Sector | Home Care Settings |
---|---|
Market Share in 2024 | 40.2% |
The home care settings segment accounted for a prominent market share of 40.2%.
The increasing availability of test kits for home care settings and the ease of collecting the sample also the easy availability of the results provided by the manufacturers is boosting the market for home care settings.
To gain a presence in the market, the leading testosterone test businesses are primarily focusing on increasing their market share and kit supply. Leading producers like LetsGetChecked and Everlywell employ tactical strategies like collaboration and expansion to increase the supply of testosterone test kits.
Attribute | Details |
---|---|
Forecast Period | 2024 to 2034 |
Historical Data Available for | 2019 to 2033 |
Market Analysis | US$ Million for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA) |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa and North Africa |
Key Market Segments Covered | Sample type, Gender, End User, and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
The global testosterone test market is worth US$ 100.0 million in 2024 and is set to expand by 6.9% over the next ten years.
The market is expected to reach US$ 208.1 million by the end of 2033.
The increasing number of manufacturing kits having a combination of different tests, digitalized reports, and the ease of sample collection are a few key trends in this market.
The United States, Germany, the United Kingdom, India, and China are expected to drive demand for the testosterone test industry.
North America is one of the key markets for testosterone tests, with the U.S. accounting for about 89.9% of the North American market in the year 2022.
Demand for testosterone tests in Europe is expected to register a growth of 7.2% over the next ten years.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Market Round Offs 1.5. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Trends & Dynamics 3.1. Per capita spending on digital scales 3.2. Key Trends Impacting the Market 3.3. Sample Type Innovation / Development Trends 3.3.1. Latest Trends and Demands 3.3.2. Latest Innovations and New Launches 3.4. Future Prospects of the Testosterone Tests Industry 3.5. Market Dynamics 3.5.1. Drivers 3.5.2. Restraints 3.5.3. Opportunity Analysis 4. Value-Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Tests USPs/Features Analysis 4.3. New Tests Launches 4.4. Regulatory Landscape, by Country 4.5. PESTEL Analysis 4.6. Porter’s Five Force Analysis 4.7. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Market Consolidation Activities 5.2.3. Increasing Prevalence of Hormonal Disorders 5.2.4. Tests Adoption / Analysis Rules 5.2.5. New Tests Development & Applications 5.2.6. Increasing Focus on Male Health 6. Global Market Demand Volume (Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Volume (Units) Analysis, 2012 to 2022 6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis *Per Capita Consumption 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Sample Type 7.2. Global Average Pricing Analysis Benchmark 7.3. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Sample Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) By Sample Type, 2012 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Sample Type, 2023 to 2033 9.3.1. Blood 9.3.2. Urine 9.3.3. Saliva 9.4. Market Attractiveness Analysis By Sample Type 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Gender 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Gender, 2012 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Gender, 2023 to 2033 10.3.1. Male 10.3.2. Female 10.4. Market Attractiveness Analysis By Gender 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 11.3.1. Hospitals 11.3.2. IVF Centers 11.3.3. Home Care settings 11.3.4. Others 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Region, 2012 to 2022 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East & Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. USA 13.3.1.2. Canada 13.3.2. By Sample Type 13.3.3. By Gender 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Sample Type 13.4.3. By Gender 13.4.4. By End User 13.5. Market Trends 13.6. Market Drivers & Restraints – Intensity Mapping 13.7. Country-Level Analysis & Forecast 13.7.1. USA Market 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast by Market Taxonomy 13.7.1.2.1. By Sample Type 13.7.1.2.2. By Gender 13.7.1.2.3. By End User 13.7.2. Canada Market 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast by Market Taxonomy 13.7.2.2.1. By Sample Type 13.7.2.2.2. By Gender 13.7.2.2.3. By End User 14. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of LATAM 14.3.2. By Sample Type 14.3.3. By Gender 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Sample Type 14.4.3. By Gender 14.4.4. By End User 14.5. Market Trends 14.6. Market Drivers & Restraints – Intensity Mapping 14.7. Country Level Analysis & Forecast 14.7.1. Brazil Market 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Sample Type 14.7.1.2.2. By Gender 14.7.1.2.3. By End User 14.7.2. Mexico Market 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Sample Type 14.7.2.2.2. By Gender 14.7.2.2.3. By End User 14.7.3. Argentina Market 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast by Market Taxonomy 14.7.3.2.1. By Sample Type 14.7.3.2.2. By Gender 14.7.3.2.3. By End User 15. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. UK 15.3.1.2. Germany 15.3.1.3. France 15.3.1.4. Italy 15.3.1.5. Spain 15.3.1.6. BENELUX 15.3.1.7. Russia 15.3.1.8. Rest of Europe 15.3.2. By Sample Type 15.3.3. By Gender 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Sample Type 15.4.3. By Gender 15.4.4. By End User 15.5. Market Trends 15.6. Market Drivers & Restraints – Intensity Mapping 15.7. Country Level Analysis & Forecast 15.7.1. UK Market 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Sample Type 15.7.1.2.2. By Gender 15.7.1.2.3. By End User 15.7.2. Germany Market 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Sample Type 15.7.2.2.2. By Gender 15.7.2.2.3. By End User 15.7.3. France Market 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Sample Type 15.7.3.2.2. By Gender 15.7.3.2.3. By End User 15.7.4. Spain Market 15.7.4.1. Introduction 15.7.4.2. Market Analysis and Forecast by Market Taxonomy 15.7.4.2.1. By Sample Type 15.7.4.2.2. By Gender 15.7.4.2.3. By End User 15.7.5. Italy Market 15.7.5.1. Introduction 15.7.5.2. Market Analysis and Forecast by Market Taxonomy 15.7.5.2.1. By Sample Type 15.7.5.2.2. By Gender 15.7.5.2.3. By End User 15.7.6. BENELUX Market 15.7.6.1. Introduction 15.7.6.2. Market Analysis and Forecast by Market Taxonomy 15.7.6.2.1. By Sample Type 15.7.6.2.2. By Gender 15.7.6.2.3. By End User 15.7.7. Russia Market 15.7.7.1. Introduction 15.7.7.2. Market Analysis and Forecast by Market Taxonomy 15.7.7.2.1. By Sample Type 15.7.7.2.2. By Gender 15.7.7.2.3. By End User 16. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Gender 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Sample Type 16.4.3. By Gender 16.4.4. By End User 16.5. Market Trends 16.6. Market Drivers & Restraints – Intensity Mapping 16.7. Country Level Analysis & Forecast 16.7.1. China Market 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Sample Type 16.7.1.2.2. By Gender 16.7.1.2.3. By End User 16.7.2. Japan Market 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Sample Type 16.7.2.2.2. By Gender 16.7.2.2.3. By End User 16.7.3. South Korea Market 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Sample Type 16.7.3.2.2. By Gender 16.7.3.2.3. By End User 17. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Indonesia 17.3.1.3. Thailand 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Sample Type 17.3.3. By Gender 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Sample Type 17.4.3. By Gender 17.4.4. By End User 17.5. Market Trends 17.6. Market Drivers & Restraints – Intensity Mapping 17.7. Country Level Analysis & Forecast 17.7.1. India Market 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Sample Type 17.7.1.2.2. By Gender 17.7.1.2.3. By End User 17.7.2. Indonesia Market 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Sample Type 17.7.2.2.2. By Gender 17.7.2.2.3. By End User 17.7.3. Thailand Market 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Sample Type 17.7.3.2.2. By Gender 17.7.3.2.3. By End User 17.7.4. Malaysia Market 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast by Market Taxonomy 17.7.4.2.1. By Sample Type 17.7.4.2.2. By Gender 17.7.4.2.3. By End User 18. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Sample Type 18.3.3. By Gender 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Sample Type 18.4.3. By Gender 18.4.4. By End User 18.5. Market Trends 18.6. Market Drivers & Restraints – Intensity Mapping 18.7. Country Level Analysis & Forecast 18.7.1. Australia Market 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Sample Type 18.7.1.2.2. By Gender 18.7.1.2.3. By End User 18.7.2. New Zealand Market 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. By Sample Type 18.7.2.2.2. By Gender 18.7.2.2.3. By End User 19. Middle East & Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. South Africa 19.3.1.4. North Africa 19.3.1.5. Rest of MEA 19.3.2. By Sample Type 19.3.3. By Gender 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Sample Type 19.4.3. By Gender 19.4.4. By End User 19.5. Market Trends 19.6. Market Drivers & Restraints – Intensity Mapping 19.7. Country Level Analysis & Forecast 19.7.1. GCC Countries Market 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast by Market Taxonomy 19.7.1.2.1. By Sample Type 19.7.1.2.2. By Gender 19.7.1.2.3. By End User 19.7.2. Türkiye Market 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast by Market Taxonomy 19.7.2.2.1. By Sample Type 19.7.2.2.2. By Gender 19.7.2.2.3. By End User 19.7.3. South Africa Market 19.7.3.1. Introduction 19.7.3.2. Market Analysis and Forecast by Market Taxonomy 19.7.3.2.1. By Sample Type 19.7.3.2.2. By Gender 19.7.3.2.3. By End User 19.7.4. North Africa Market 19.7.4.1. Introduction 19.7.4.2. Market Analysis and Forecast by Market Taxonomy 19.7.4.2.1. By Sample Type 19.7.4.2.2. By Gender 19.7.4.2.3. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players 20.3. Market Concentration 21. Competition Analysis 21.1. Competition Dashboard 21.2. Branding and Promotional Strategies, By Key Players 21.3. Key Development Analysis 21.4. Competition Deep Dive 21.4.1. Abbexa 21.4.1.1. Overview 21.4.1.2. Sample Type Portfolio 21.4.1.3. Key Financials 21.4.1.4. SWOT Analysis 21.4.1.5. Key Developments 21.4.1.6. Sales Footprint 21.4.1.7. Strategy Overview 21.4.1.7.1. Marketing Strategy 21.4.1.7.2. Sample Type Strategy 21.4.1.7.3. Channel Strategy 21.4.2. Imaware 21.4.3. LetsGetChecked 21.4.4. Everlywell 21.4.5. Boditech 21.4.6. myLAB Box 21.4.7. Verisana 21.4.8. Cerascreen 21.4.9. MediChecks 21.4.10. Genway Biotech 21.4.11. Hone Health 21.4.12. Humankind Ventures Ltd. 21.4.13. Diagnostic Automation/Cortez Diagnostics Inc. 21.4.14. Myclinic.ie 21.4.15. Healthy Human Labs Ltd. 21.4.16. MyBioSource 21.4.17. Bluecrest Wellness 21.4.18. Testochecker 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports